Literature DB >> 30510100

Neisseria gonorrhoeae PBP3 and PBP4 Facilitate NOD1 Agonist Peptidoglycan Fragment Release and Survival in Stationary Phase.

Ryan E Schaub1, Krizia M Perez-Medina1, Kathleen T Hackett1, Daniel L Garcia1, Joseph P Dillard2.   

Abstract

Neisseria gonorrhoeae releases peptidoglycan fragments during growth, and these molecules induce an inflammatory response in the human host. The proinflammatory molecules include peptidoglycan monomers, peptidoglycan dimers, and free peptides. These molecules can be released by the actions of lytic transglycosylases or an amidase. However, >40% of the gonococcal cell wall is cross-linked, where the peptide stem on one peptidoglycan strand is linked to the peptide stem on a neighboring strand, suggesting that endopeptidases may be required for the release of many peptidoglycan fragments. Therefore, we characterized mutants with individual or combined mutations in genes for the low-molecular-mass penicillin-binding proteins PBP3 and PBP4. Mutations in either dacB, encoding PBP3, or pbpG, encoding PBP4, did not significantly reduce the release of peptidoglycan monomers or free peptides. A mutation in dacB caused the appearance of a larger-sized peptidoglycan monomer, the pentapeptide monomer, and an increased release of peptidoglycan dimers, suggesting the involvement of this enzyme in both the removal of C-terminal d-Ala residues from stem peptides and the cleavage of cross-linked peptidoglycan. Mutation of both dacB and pbpG eliminated the release of tripeptide-containing peptidoglycan fragments concomitantly with the appearance of pentapeptide and dipeptide peptidoglycan fragments and higher-molecular-weight peptidoglycan dimers. In accord with the loss of tripeptide peptidoglycan fragments, the level of human NOD1 activation by the dacB pbpG mutants was significantly lower than that by the wild type. We conclude that PBP3 and PBP4 overlap in function for cross-link cleavage and that these endopeptidases act in the normal release of peptidoglycan fragments during growth.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  NOD1; NOD1 agonist; carboxypeptidase; endopeptidase; penicillin-binding proteins; peptidoglycan

Mesh:

Substances:

Year:  2019        PMID: 30510100      PMCID: PMC6346134          DOI: 10.1128/IAI.00833-18

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Mutation of a single lytic transglycosylase causes aberrant septation and inhibits cell separation of Neisseria gonorrhoeae.

Authors:  Karen A Cloud; Joseph P Dillard
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

2.  Neisseria gonorrhoeae uses two lytic transglycosylases to produce cytotoxic peptidoglycan monomers.

Authors:  Karen A Cloud-Hansen; Kathleen T Hackett; Daniel L Garcia; Joseph P Dillard
Journal:  J Bacteriol       Date:  2008-06-20       Impact factor: 3.490

3.  Peptidoglycan degradation by specialized lytic transglycosylases associated with type III and type IV secretion systems.

Authors:  Doris Zahrl; Maria Wagner; Karin Bischof; Michaela Bayer; Barbara Zavecz; Andreas Beranek; Christoph Ruckenstuhl; Gernot E Zarfel; Günther Koraimann
Journal:  Microbiology       Date:  2005-11       Impact factor: 2.777

4.  Autolysis of Neisseria gonorrhoeae.

Authors:  B H Hebeler; F E Young
Journal:  J Bacteriol       Date:  1975-05       Impact factor: 3.490

5.  Amidase Activity of AmiC Controls Cell Separation and Stem Peptide Release and Is Enhanced by NlpD in Neisseria gonorrhoeae.

Authors:  Jonathan D Lenz; Elizabeth A Stohl; Rosanna M Robertson; Kathleen T Hackett; Kathryn Fisher; Kalia Xiong; Mijoon Lee; Dusan Hesek; Shahriar Mobashery; H Steven Seifert; Christopher Davies; Joseph P Dillard
Journal:  J Biol Chem       Date:  2016-03-16       Impact factor: 5.157

6.  Lytic transglycosylases LtgA and LtgD perform distinct roles in remodeling, recycling and releasing peptidoglycan in Neisseria gonorrhoeae.

Authors:  Ryan E Schaub; Yolande A Chan; Mijoon Lee; Dusan Hesek; Shahriar Mobashery; Joseph P Dillard
Journal:  Mol Microbiol       Date:  2016-09-26       Impact factor: 3.501

7.  Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.

Authors:  Naohiro Inohara; Yasunori Ogura; Ana Fontalba; Olga Gutierrez; Fernando Pons; Javier Crespo; Koichi Fukase; Seiichi Inamura; Shoichi Kusumoto; Masahito Hashimoto; Simon J Foster; Anthony P Moran; Jose L Fernandez-Luna; Gabriel Nuñez
Journal:  J Biol Chem       Date:  2003-01-04       Impact factor: 5.157

8.  The low-molecular-mass, penicillin-binding proteins DacB and DacC combine to modify peptidoglycan cross-linking and allow stable Type IV pilus expression in Neisseria gonorrhoeae.

Authors:  Kyle P Obergfell; Ryan E Schaub; Lauren L Priniski; Joseph P Dillard; H Steven Seifert
Journal:  Mol Microbiol       Date:  2018-04-15       Impact factor: 3.979

9.  Studies on gonococcus infection. II. Freeze-fracture, freeze-etch studies on gonocci.

Authors:  J Swanson
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307

10.  A Single Dual-Function Enzyme Controls the Production of Inflammatory NOD Agonist Peptidoglycan Fragments by Neisseria gonorrhoeae.

Authors:  Jonathan D Lenz; Kathleen T Hackett; Joseph P Dillard
Journal:  MBio       Date:  2017-10-17       Impact factor: 7.867

View more
  2 in total

1.  The AmiC/NlpD Pathway Dominates Peptidoglycan Breakdown in Neisseria meningitidis and Affects Cell Separation, NOD1 Agonist Production, and Infection.

Authors:  Jia Mun Chan; Kathleen T Hackett; Katelynn L Woodhams; Ryan E Schaub; Joseph P Dillard
Journal:  Infect Immun       Date:  2022-02-14       Impact factor: 3.609

2.  Structural Modeling of Cell Wall Peptidase CwpFM (EntFM) Reveals Distinct Intrinsically Disordered Extensions Specific to Pathogenic Bacillus cereus Strains.

Authors:  Seav-Ly Tran; Delphine Cormontagne; Jasmina Vidic; Gwenaëlle André-Leroux; Nalini Ramarao
Journal:  Toxins (Basel)       Date:  2020-09-14       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.